The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the ...

Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide ...

Initiated Phase 2 STRIDES trial of azelaprag in combination with tirzepatide for obesityCompleted $238.3 million initial public offering and ...

Lord Vallance stated the government sees investment, innovation, and public-private partnership as crucial to UK healthcare.

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of ...

We recently compiled a list of the 10 Best Reddit Stocks To Buy Right Now. In this article, we are going to take a look at where Eli Lilly And Co.

putting compounding of tirzepatide into a gray area. Meanwhile, semaglutide remains on the shortages list, but Novo Nordisk ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

The recent success of drug therapies such as semaglutide and tirzepatide has fueled obesity research ... as those seen with other GLP-1 receptor agonists were reported. The Company is also evaluating ...

The clinical-stage drugmaker is developing an anti-obesity drug that could go on to produce record-breaking sales.